Measurement of renal function during drug development

British Journal of Clinical Pharmacology

Volumn 54, Issue 1, 2002, Pages 87-95

  Brater, D Craig ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Active secretion; Filtration; Metabolism; Renal excretion

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 5 HYDROXYINDOLEACETIC ACID; CARBOXYLIC ACID; CILASTATIN; CIPROFIBRATE; CLOFIBRATE; DEXTRAN; DIATRIZOATE; EDETIC ACID; GLOBULIN; GLYCOPROTEIN P; HISTAMINE; IMIPENEM; INSULIN; IODOHIPPURIC ACID; IOTALAMIC ACID; KETOPROFEN; LOOP DIURETIC AGENT; M PROTEIN; MICROGLOBULIN ALPHA2; N METHYLNICOTINAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEOSIDE; PENICILLIN G; PENTETIC ACID; POLYCYCLIC AROMATIC HYDROCARBON; PROCAINAMIDE; SUPEROXIDE DISMUTASE; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CONFERENCE PAPER; CREATININE CLEARANCE; DRUG ELIMINATION; DRUG METABOLISM; GLOMERULUS FILTRATION RATE; HUMAN; INULIN CLEARANCE; KIDNEY BLOOD FLOW; KIDNEY FUNCTION TEST; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; URINARY EXCRETION; URINE PH;

DRUG EVALUATION; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS;

EID: 0036971097     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2002.01625.x     Document Type: Conference Paper

References (48)

1. Zaltzman JS, Whiteside C, Cattran DC, Lopez FM, Logan AG. Accurate measurement of impaired glomerular filtration using single-dose oral cimetidine. Am J Kidney Dis 1996; 27: 504-511.
2. Roubenoff R, Drew H, Moyer M, Petri M, Whiting-O'Keefe Q, Hellmann DB. Oral cimetidine improves the accuracy and precision of creatinine clearance in lupus nephritis. Ann Intern Med 1990; 113: 501-506.
3. Bianchi C, Donadio C, Tramonti G. Noninvasive methods for the measurement of total renal function. Nephron 1981; 28: 53-57.
4. Levey AS. Measurement of renal function in chronic renal disease. Kidney Int 1990; 38: 167-184.
5. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28: 830-838.
6. Walser M, Drew H, LaFrance ND. Creatinine measurements often yield false estimates of progression in chronic renal failure. Kidney Int 1988; 34: 412-418.
7. Dossetor JB. Creatininemia versus uremia. The relative significance of blood urea nitrogen and serum creatinine concentrations in azotemia. Ann Intern Med 1966; 65: 1287-1299.
8. 131I. Circulation 1967; 36: 441-447.
9. 125I-labeled sodium iothalamate (Glofil) and of inulin. Mayo Clin Proc 1971; 46: 690-691.
10. Dalmeida W, Suki WN. Measurement of GFR with non-radioisotopic radio contrast agents. Kidney Int 1988; 34: 725-728.
11. Choyke PL, Austin HA, Frank JA, et al. Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate. Kidney Int 1992; 41: 1595-1158.
12. 2-microglobulin. Nephron 1981; 29: 30-35.
13. Takahira R, Yonemura K, Yonekawa O, et al. Tryptophan glycoconjugate as a novel marker of renal function. Am J Med 2001; 110: 192-197.
14. Maïza A, Waldek S, Ballardie FW, Daley-Yates PT. Estimation of renal tubular secretion in man, in health and disease, using endogenous N-1-methylnicotinamide. Nephron 1992; 60: 12-16.
15. Hannedouche T, Laude D, Déchaux M, Grünfeld J-P, Elghozi J-L. Plasma 5-hydroxyindoleacetic acid as an endogenous index of renal plasma flow. Kidney Int 1989; 35: 95-98.
16. Brater DC, Sokol PP, Hall SD, McKinney TD. Renal elimination of drugs: Methods and determinants. In The Kidney, Physiology and Pathophysiology, eds Seldin DW, Giebisch G. New York: Raven Press, 1992: 3597-3628.
17. Tucker GT. Measurement of the renal clearance of drugs. Br J Clin Pharmacol 1981; 12: 761-770.
18. Keeler R. The effects of 'dead space' and urine flow changes on measurements of glomerular filtration rate by clearance methods. Can J Physiol Pharmacol 1983; 61: 435-438.
19. Brater DC. Renal disorders and the influence of renal function on drug disposition. In Melmon and Morrelli's Clinical Pharmacology, 4th Edn, eds Carruthers SG, Hoffman BB, Melmon KL, Nierenberg DW. McGraw-Hill, 2000: 363-400.
20. Brater DC, Kaojarern S, Benet LZ, et al. Renal excretion of pseudoephedrine. Clin Pharmacol Ther 1980; 28: 690-694.
21. Ferry N, Bernard N, Pozet N, et al. The influence of renal insufficiency and haemodialysis on the kinetics of ciprofibrate. Br J Clin Pharmacol 1989; 28: 675-681.
22. Sallustio BC, Purdie YJ, Birkett DJ, Meffin PJ. Effect of renal dysfunction on the individual components of the acyl-glucuronide futile cycle. J Pharmacol Exp Ther 1989; 251: 288-294.
23. Faed EM. Properties of acyl glucuronides: Implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab Rev 1984; 15: 1213-1249.
24. Grubb NG, Rudy DW, Brater DC, Hall SD. Stereoselective phramacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: Evidence for a futile cycle of elimination. Br J Clin Pharmacol 1999; 48: 494-500.
25. Brater DC, Hall SD. Disposition and dose requirements of drugs in renal insufficiency. In The Kidney. Physiology and Pathophysiology, 3rd Edn, eds Seldin DW, Giebisch G. Lippincott. Philadelphia: Williams & Wilkins, 2000: 2923-2942.
26. Burckhardt G, Ullrich KJ. Organic anion transport across the contraluminal membrane - Dependence on sodium. Kidney Int 1989; 36: 370-377.
27. Masereeuw R, Russel FGM, Miller DS. Multiple pathways of organic anion secretion in renal proximal tubule revealed by confocal microscopy. Am J Physiol 1996; 271: F1173-F1182.
28. Lu R, Chan BS, Schuster VL. Cloning of the human kidney PAH transporter: Narrow substrate specificity and regulation by protein kinase C. Am J Physiol 1999; 276: F295-F303.
29. Hosoyamada M, Sekine T, Kanai Y, Endou H. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol 1999; 276: F122-F128.
30. Van Aubel RAMH, Masereeuw R, Russel FGM. Molecular pharmacology of renal organic anion transporters. Am J Physiol 2000; 279: F216-F232.
31. Kosoglou T, Rocci ML, Vlasses PH. Trimethoprim alters the disposition of procainamide and N-acetylprocainamide. Clin Pharmacol Ther 1988; 44: 467-477.
32. Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 1994; 372: 549-552.
33. Pietruck F, Ullrich KJ. Transport interactions of different organic cations during their excretion by the intact rat kidney. Kidney Int 1995; 47: 1647-1657.
34. McKinney TD, Speeg KV. Cimetidine and procainamide secretion by proximal tubules in vitro. Am J Physiol 1982; 242: F672-F680.
35. Rennick BR. Renal tubule transport of organic cations. Am J Physiol 1981; 240: F83-F89.
36. Notterman DA, Drayer DE, Metakis L, Reidenberg MM. Stereoselective renal tubular secretion of quinidine and quinine. Clin Pharmacol Ther 1986, 511-517.
37. Miyamoto Y, Tiruppathi C, Ganapathy V, Leibach FH. Multiple transport systems for organic cations in renal brush-border membrane vesicles. Am J Physiol 1989; 256: F540-F548.
38. Brett CM, Washington CB, Ott RJ, Gutierrez MM, Giacomini KM. Interaction of nucleoside analogues with the sodium-nucleoside transport system in brush border membrane vesicles from human kidney. Pharm Res 1993; 10: 423-426.
39. Tsuruoka S, Sugimoto K-I, Fujimura A, Imai M, Asano Y, Muto S. P-glycoprotein-mediated drug secretion in mouse proximal tubule perfused in vitro. J Am Soc Nephrol 2001; 12: 177-181.
40. Verschraagen M, Koks CHW, Schellens JHM, Beijnen JH. P-glycoprotein system as a determinant of drug interactions: The case of digoxin-verapamil. Pharmacol Res 1999; 40: 301-306.
41. Wakasugi H, Yano I, Ito T, et al. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. Clin Pharmacol Ther 1998; 64: 123-128.
42. Hori R, Okamura N, Aiba T, Tanigawara Y. Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney. J Pharmacol Exp Ther 1993; 266: 1620-1625.
43. Okamura N, Hirai M, Tanigawara Y, et al. Digoxin-cyclosporin A interaction, modulation of the multidrug transporter P-glycoprotein in the kidney. J Pharmacol Exp Ther 1993; 266: 1614-1619.
44. Ernest S, Bello-Reuss E. P-glycoprotein functions and substrates: Possible roles of MDR1 gene in the kidney. Kidney Int 1998; 53: S11-S17.
45. Dutt A, Heath LA, Nelson JA. P-glycoprotein and organic cation secretion by the mammalian kidney. J Pharmacol Exp Ther 1994; 269: 1254-1260.
46. Weiner IM, Mudge GH. Renal tubular mechanisms for excretion of organic acids and bases. Am J Med 1964; 36: 743-762.
47. Scribner BH, Crawford MA, Dempster WJ. Urinary excretion by nonionic diffusion. Am J Physiol 1959; 196: 1135-1140.
48. Milne MD, Scribner BH, Crawford MA. Non-ionic diffusion and the excretion of weak acids and bases. Am J Med 1958; 24: 709-729.